At the time of its creation, the Skokie facility employed approximately 15 German expats to support the setting up of the core processes at the site. Today, the facility has a working staff of around 100 employees, almost all of whom are from the US. In addition to its growing employee population, the facility has also doubled in size from its original 24,000 sq. ft. to 50,000 sq. ft. today. To access the press release, click here.
“Our Skokie facility is a clear demonstration of the successful strategy we put into place in the second half of the 2000s,” said Vetter Managing Director Thomas Otto “That strategy was to be closer to the injectable development projects taking place in the US. The facility is also further proof of our family related business philosophy. By bringing expats to the facility first, and then gradually transitioning primarily to local employees, we created strong intercultural teams and secured knowledge transfer from our German specialists to our US experts.”
Vetter Development Service Chicago has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug products from early stages to Phase II, with transfer to the company’s commercial manufacturing capabilities in Europe. As a strategic partner with a global network of excellence, Vetter provides proven drug delivery systems specifically designed for the clinical needs and timelines of complex compounds. For more on Vetter’s Chicago site, please see: https://www.vetter-pharma.com/en/clinical-manufacturing-us